| P50 | author | Sae-Won Han | Q91404079 |
| | Chan-Young Ock | Q102370059 |
| | Yung-Jue Bang | Q16180903 |
| | Seock-Ah Im | Q58821370 |
| | Do-Youn Oh | Q87569618 |
| | Tae-You Kim | Q87569625 |
| | Kyung Hun Lee | Q87845591 |
| | Joongyub Lee | Q88097845 |
| P2093 | author name string | Tae-Yong Kim | |
| P2860 | cites work | Chemotherapy for advanced gastric cancer | Q24236634 |
| | Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial | Q24685678 |
| | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 |
| | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
| | Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 |
| | Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach | Q29614698 |
| | Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 |
| | Abnormal diurnal weight gain among institutionalized patients with manic-depressive spectrum disorders | Q30451902 |
| | Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis | Q30586297 |
| | Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group | Q34057488 |
| | Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance? | Q35106132 |
| | Physical exercise for cancer patients with advanced disease: a randomized controlled trial | Q35599837 |
| | Sarcopenia during androgen-deprivation therapy for prostate cancer | Q36212442 |
| | Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. | Q36331273 |
| | Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? | Q36694116 |
| | Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis | Q37985805 |
| | Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer | Q42078486 |
| | Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia | Q42989201 |
| | Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma | Q43188323 |
| | Obesity paradox in cancer: new insights provided by body composition | Q43860519 |
| | Abnormal diurnal weight gain among long-term patients with schizophrenic disorders | Q44248394 |
| | Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer | Q45850052 |
| | Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? | Q47282777 |
| | Gastrointestinal symptoms and weight loss in cancer patients receiving chemotherapy | Q47304333 |
| | Diurnal pattern of water and electrolyte excretion and body weight in idiopathic orthostatic hypotension. The effect of three treatments | Q47335499 |
| | Adjustment for regression dilution in epidemiological regression analyses. | Q52900641 |
| | The impact of body mass index dynamics on survival of patients with advanced pancreatic cancer receiving chemotherapy. | Q54468203 |
| P433 | issue | 2 | |
| P304 | page(s) | 597-606 | |
| P577 | publication date | 2015-03-08 | |
| P1433 | published in | Gastric Cancer | Q15724608 |
| P1476 | title | Weight loss at the first month of palliative chemotherapy predicts survival outcomes in patients with advanced gastric cancer | |
| P478 | volume | 19 | |